Efficacy News and Research

RSS
Researchers present new data for diagnosis and management of beast cancer

Researchers present new data for diagnosis and management of beast cancer

Pfizer announces results from studies evaluating neratinib

Pfizer announces results from studies evaluating neratinib

Texas researchers identify new detection method for circulating tumor cells

Texas researchers identify new detection method for circulating tumor cells

Positive Phase 2 study results of CDX-011 reported by Celldex Therapeutics

Positive Phase 2 study results of CDX-011 reported by Celldex Therapeutics

Enrollment of patients for Phase IIb clinical trial of WBI-1001 commenced

Enrollment of patients for Phase IIb clinical trial of WBI-1001 commenced

Phase 2 pivotal trial of AC220 initiated by Ambit Biosciences

Phase 2 pivotal trial of AC220 initiated by Ambit Biosciences

Zevalin clinical data presented at 2009 ASH meeting

Zevalin clinical data presented at 2009 ASH meeting

Pfizer's Prevenar 13 granted European marketing authorization

Pfizer's Prevenar 13 granted European marketing authorization

Murad expands its product development department

Murad expands its product development department

ThromboGenics initiates Phase II trial of microplasmin for wet AMD

ThromboGenics initiates Phase II trial of microplasmin for wet AMD

HST Global and HMD team up to develop curriculum for FIT protocol

HST Global and HMD team up to develop curriculum for FIT protocol

Italy's economically disadvantaged people have higher rates of hospitalization for ACSC disorders

Italy's economically disadvantaged people have higher rates of hospitalization for ACSC disorders

Tasigna demonstrates greater efficacy over Gleevec in chronic Ph+ CML patients

Tasigna demonstrates greater efficacy over Gleevec in chronic Ph+ CML patients

Initiation of multi-national Phase III study of Stimuvax announced

Initiation of multi-national Phase III study of Stimuvax announced

DMC recommends Novartis and Nordic Bioscience to continue oral calcitonin Phase III studies

DMC recommends Novartis and Nordic Bioscience to continue oral calcitonin Phase III studies

Fulvestrant 500 mg reduces risk of disease progression in women with metastatic breast cancer

Fulvestrant 500 mg reduces risk of disease progression in women with metastatic breast cancer

FDA Drugs Advisory Committee recommends approval for Gilead Sciences' aztreonam for inhalation solution

FDA Drugs Advisory Committee recommends approval for Gilead Sciences' aztreonam for inhalation solution

Positive results from BioAlliance Pharma's acyclovir Lauriad phase III trial

Positive results from BioAlliance Pharma's acyclovir Lauriad phase III trial

FDA approves Azaya Therapeutics' Taxotere for Phase I clinical study

FDA approves Azaya Therapeutics' Taxotere for Phase I clinical study

ARTs safe without routine lab tests, Lancet study finds

ARTs safe without routine lab tests, Lancet study finds

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.